Understanding Each Component CJC-1295 (with DAC) CJC-1295 is a growth hormone releasing hormone (GHRH) analog that extends the half-life of naturally occurring GHRH
Published trials are sparse, but a 2023 observational study reported modest additional weight loss (35 lbs over 12 weeks) with combination therapy versus single-agent, though nausea and dizziness occurred in 34% of patients
If you get digestive symptoms after taking B12, often there is a bacterial overgrowth or possibly fungal overgrowth creating the digestive symptoms
The device, the serum, the post-procedure barrier-support routine, the photoprotection plan, the cadence, and the contraindication awareness are all part of one treatment
Maintenance phase Once the therapeutic level is established, the maintenance phase reduces injection frequency while sustaining the tissue repair environment
Together, they combine full-face brightening with precise spot treatment for faster, more even results